WASHINGTON — Dr. Robert Malone, a physician and prominent voice aligned with Health and Human Services Secretary Robert F. Kennedy Jr., is stepping down from the Advisory Committee on Immunization Practices (ACIP), a federal panel that advises the Centers for Disease Control and Prevention on vaccine policy. The move comes after a federal judge halted the work of the committee, throwing into question recent changes to the nation’s vaccine schedule. Malone’s departure, first reported by Roll Call, signals a further shift in the ongoing debate over vaccine recommendations and federal oversight.
Malone, who has been a vocal advocate for questioning established vaccine protocols, reportedly told CQ Roll Call in a text message, “Suffice to say I do not like drama, and have better things to do.” He did not respond to a phone call from STAT, according to the publication. The decision to step aside reflects the escalating legal and political challenges surrounding the committee’s recent actions, which have been met with significant opposition from medical organizations and public health advocates.
A Judge’s Ruling and a Disrupted Vaccine Agenda
The catalyst for Malone’s departure is the March 20 ruling by U.S. District Judge Brian E. Murphy, who found that ACIP had acted improperly in its recent deliberations. As STAT News reported, the judge concluded that the panel’s decisions were not supported by sufficient evidence and restored the original, previously recommended vaccine schedule. The American Academy of Pediatrics (AAP) had filed a lawsuit challenging the changes, arguing they were not based on sound scientific principles.
The changes in question stemmed from a broader reshaping of vaccine policies initiated by Kennedy after his appointment as HHS Secretary last year. Kennedy dismissed the previous iteration of ACIP, alleging undue influence from pharmaceutical interests. He then appointed a new panel, including Malone, tasked with reviewing and revising the national vaccine schedule. One of the committee’s first actions was to vote to delay the hepatitis B birth dose given to infants, a decision that drew immediate criticism from medical experts.
The Role of Robert Malone and Previous Controversies
Dr. Malone’s appointment to ACIP was itself controversial, given his history of promoting unsubstantiated claims about vaccine safety. He gained prominence during the COVID-19 pandemic for his views on mRNA vaccines, which he has characterized as potentially dangerous despite overwhelming scientific consensus to the contrary. His inclusion on the committee raised concerns among public health officials about the potential for biased recommendations.
Prior to the judge’s ruling, Malone made conflicting statements regarding the status of ACIP. He initially declared the panel had been disbanded, only to later clarify that his comments were a miscommunication. He also expressed strong disapproval of Judge Murphy’s decision on his X account (formerly Twitter), calling for the judge’s impeachment and labeling him a “rogue judge.”
Judge Brian Murphy is a rogue judge. He should be impeached. https://t.co/example
— Robert W Malone MD, MS (@RWMaloneMD) March 22, 2026
What’s Next for Vaccine Policy?
The Department of Health and Human Services has not yet indicated whether it will appeal Judge Murphy’s ruling. If the decision stands, the original vaccine schedule will remain in effect. The future of ACIP itself is also uncertain. While the committee remains technically in existence, its authority has been significantly diminished by the court’s decision. The Biden administration, which is expected to take office in January 2027, will likely play a key role in determining the committee’s future direction.
The situation highlights the growing politicization of vaccine policy and the challenges of balancing public health concerns with individual liberties. The debate over vaccine mandates and recommendations is likely to continue, particularly as new vaccines are developed, and introduced. Understanding the role of advisory committees like ACIP, and the scientific evidence that informs their decisions, is crucial for informed public discourse.
The Department of Health and Human Services is expected to announce its decision regarding an appeal of Judge Murphy’s ruling by April 15, 2026. Further updates on the status of ACIP and federal vaccine policy will be posted on the Centers for Disease Control and Prevention website.
This is a developing story. Share your thoughts in the comments below, and please consider sharing this article with your network.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. We see essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
